STRO vs ZBRA · rev $62.0M vs P/E 28, rev $4.98B
Sutro Biopharma (STRO) versus Zebra Technologies Corporation (ZBRA) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Zebra Technologies Corporation (ZBRA) is a communication equipment company listed on NASDAQ.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported ZBRA revenue for 2024-12-31 was $4.98B. Net income was $528.0M. Revenue was up 8.7% from 2023-12-31 to 2024-12-31. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
STRO currently screens at market cap $470.8M. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
Not investment advice. Open the STRO and ZBRA stock pages for the full models.
Not investment advice.